National Institutes of Health:Development and Characterization of Animal Models for Aging Research (R21) Grant
http://www07.grants.gov/search/search.do?&mode=VIEW&flag2006=false&oppId=50029
|
Funding Opportunity Number: |
PA-10-015 |
|
Posted Date: |
Oct 29, 2009 |
|
Current Closing Date for Applications: |
Jan 07, 2013 |
|
Award Ceiling: |
$200,000 |
|
CFDA Number(s): |
93.866 -- Aging Research |
|
Cost Sharing or Matching Requirement: |
No |
Purpose: The purpose of this announcement is to describe areas of research of particular interest to the National Institute on Aging. This FOA seeks to promote research that develops, characterizes, refines and enhances model systems for aging research, including but not limited to animal models, cell lines, and informatics. This FOA issued by the National Institute on Aging, National Institutes of Health, encourages Research Project Grant (R01) applications that propose to: characterize aging at the physiological, biochemical and functional levels in existing animal models, including but not limited to animal models currently used in other scientific fields that have potential to benefit aging research; develop new animal models for aging research; develop unique cell lines for aging research; use comparative biology to identify models of highest priority for aging research; or develop informatics that enhance the utilization of animals for aging research.
Mechanism of Support: This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-014, that encourages applications under the R01 mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.
http://grants.nih.gov/grants/guide/pa-files/PA-10-015.html
U.S. Department of Health and Human Services
National Institutes of Health:Enabling Technologies in DNA Repair Research (R21) Grant
http://www07.grants.gov/search/search.do?&mode=VIEW&flag2006=false&oppId=50033
|
Funding Opportunity Number: |
PAR-10-016 |
|
Posted Date: |
Oct 29, 2009 |
|
Current Closing Date for Applications: |
Jan 10, 2010 |
|
Award Ceiling: |
$200,000 |
|
CFDA Number(s): |
93.113 -- Environmental Health |
|
93.393 -- Cancer Cause and Prevention Research |
|
|
Cost Sharing or Matching Requirement: |
No |
Purpose: This Funding Opportunity Announcement (FOA) is designed to support multidisciplinary teams to develop enabling technologies that will facilitate and stimulate translation of basic research in DNA damage and repair to human population or clinical studies. These projects will develop new tools to measure global DNA repair capacity in individuals or responses in individual DNA repair pathways activated in response to DNA damaging agents. The assays are expected to enable the study of DNA damage response in exposed individuals in clinical and epidemiological studies. Thus, a key goal is the identification and verification of reproducible biomarkers that indicate the levels of specific repair activity or mutagenic outcomes and would provide the basis for assay development. Field or pilot testing of tools or assays is encouraged. Support will be provided for the development of novel assays for detecting DNA damage and repair or for improving existing measures. It is expected that these improved technologies will be appropriate and scalable for epidemiological and clinical studies.
Mechanism of Support: This FOA will use the NIH Exploratory/Developmental (R21) grant mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Budget and Project Period: The total project period for an application submitted in response to this funding opportunity may not exceed two years. For an R21, direct costs are limited to $275,000 over a two-year period, with no more than $200,000 in direct costs allowed in any single year.
http://grants.nih.gov/grants/guide/pa-files/PAR-10-016.html
U.S. Department of Health and Human Services
National Institutes of Health:NEI Clinical Study Planning Grant Program (R34) Grant
http://www07.grants.gov/search/search.do?&mode=VIEW&flag2006=false&oppId=50034
|
Funding Opportunity Number: |
PAR-10-017 |
|
Posted Date: |
Oct 29, 2009 |
|
Current Closing Date for Applications: |
Jan 07, 2013 |
|
CFDA Number(s): |
93.867 -- Vision Research |
|
Cost Sharing or Matching Requirement: |
No |
Purpose: The National Eye Institute (NEI) supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies. At the time of submission, applications requesting support for these activities are expected to provide detailed information regarding the study’s rationale, design, analytic techniques, protocols and procedures, facilities and environment, organizational structure, and collaborative arrangements. This information is best conveyed in a well-documented Manual of Procedures (MOP), the development of which represents a costly and time-consuming activity. The Clinical Study Planning Grant is designed to facilitate activities central to the refinement of a study’s protocol and procedures and the development of a detailed MOP. The NEI Clinical Study Planning Grant may be used to support the development of a MOP, as well as to conduct preliminary studies to refine study procedures and/or assess recruitment potential. The Clinical Study Planning Grant is applicable to both epidemiologic and clinical trial research studies.
Mechanism of Support: This FOA will utilize the Clinical Study Planning Grant Program for Clinical Trials (R34) mechanism Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Budget and Project Period: The total project period may not exceed two years. Direct costs are limited to $150,000 per year.
http://grants.nih.gov/grants/guide/pa-files/PAR-10-017.html